Details for New Drug Application (NDA): 209060
✉ Email this page to a colleague
The generic ingredient in AMINOCAPROIC ACID is aminocaproic acid. There are six drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the aminocaproic acid profile page.
Summary for 209060
| Tradename: | AMINOCAPROIC ACID |
| Applicant: | Sunny |
| Ingredient: | aminocaproic acid |
| Patents: | 0 |
Pharmacology for NDA: 209060
| Physiological Effect | Decreased Fibrinolysis |
Medical Subject Heading (MeSH) Categories for 209060
Suppliers and Packaging for NDA: 209060
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| AMINOCAPROIC ACID | aminocaproic acid | TABLET;ORAL | 209060 | ANDA | American Health Packaging | 60687-739 | 60687-739-25 | 30 BLISTER PACK in 1 CARTON (60687-739-25) / 1 TABLET in 1 BLISTER PACK (60687-739-95) |
| AMINOCAPROIC ACID | aminocaproic acid | TABLET;ORAL | 209060 | ANDA | Vitruvias Therapeutics | 69680-115 | 69680-115-00 | 100 TABLET in 1 BOTTLE (69680-115-00) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 500MG | ||||
| Approval Date: | Nov 27, 2018 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 1GM | ||||
| Approval Date: | Nov 27, 2018 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
